| Year |
Citation |
Score |
| 2024 |
Rydzewski NR, Shi Y, Li C, Chrostek MR, Bakhtiar H, Helzer KT, Bootsma ML, Berg TJ, Harari PM, Floberg JM, Blitzer GC, Kosoff D, Taylor AK, Sharifi MN, Yu M, et al. A platform-independent AI tumor lineage and site (ATLAS) classifier. Communications Biology. 7: 314. PMID 38480799 DOI: 10.1038/s42003-024-05981-5 |
0.414 |
|
| 2022 |
Bootsma M, McKay RR, Emamekhoo H, Bade RM, Schehr JL, Mannino MC, Singh A, Wolfe SK, Schultz ZD, Sperger J, Xie W, Signoretti S, Kyriakopoulos CE, Kosoff D, Abel EJ, ... ... Sharifi M, et al. Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2200219. PMID 35617646 DOI: 10.1200/JCO.22.00219 |
0.426 |
|
| 2022 |
Kalra M, Henry E, McCann K, Karuturi MS, Bustamante Alvarez JG, Parkes A, Wesolowski R, Wei M, Mougalian SS, Durm G, Qin A, Schonewolf C, Trivedi M, Armaghani AJ, Wilson FH, ... ... Sharifi MN, et al. Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study. Jmir Cancer. 8: e33859. PMID 35588361 DOI: 10.2196/33859 |
0.314 |
|
| 2020 |
Sharifi MN, Anandan A, Grogan P, O'Regan RM. Therapy after cyclin-dependent kinase inhibition in metastatic hormone receptor-positive breast cancer: Resistance mechanisms and novel treatment strategies. Cancer. PMID 32426848 DOI: 10.1002/Cncr.32931 |
0.37 |
|
| 2019 |
Sharifi M, Wisinski K, Burkard M, Tevaarwerk A, Tamkus D, Chan N, Truica C, Danciu O, Hoskins K, O'Regan R. Abstract OT1-02-01: Phase I trial of bicalutamide and ribociclib in androgen receptor-positive triple negative breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Ot1-02-01 |
0.329 |
|
| 2018 |
Mowers EE, Sharifi MN, MacLeod KF. Functions of autophagy in the tumor microenvironment and cancer metastasis. The Febs Journal. PMID 29356327 DOI: 10.1111/Febs.14388 |
0.776 |
|
| 2017 |
Sharifi MN, Mowers EE, Macleod KF. Autophagic degradation of focal adhesions underlies metastatic cancer dissemination. Molecular & Cellular Oncology. 4: e1198299. PMID 28401177 DOI: 10.1080/23723556.2016.1198299 |
0.766 |
|
| 2016 |
Mowers EE, Sharifi MN, Macleod KF. Autophagy in cancer metastasis. Oncogene. 36: 1619-1630. PMID 27593926 DOI: 10.1038/Onc.2016.333 |
0.739 |
|
| 2016 |
Mowers EE, Sharifi MN, Macleod KF. Novel insights into how autophagy regulates tumor cell motility. Autophagy. 0. PMID 27439889 DOI: 10.1080/15548627.2016.1203487 |
0.757 |
|
| 2016 |
Sharifi MN, Mowers EE, Drake LE, Collier C, Chen H, Zamora M, Mui S, Macleod KF. Autophagy Promotes Focal Adhesion Disassembly and Cell Motility of Metastatic Tumor Cells through the Direct Interaction of Paxillin with LC3. Cell Reports. PMID 27184837 DOI: 10.1016/J.Celrep.2016.04.065 |
0.779 |
|
| 2015 |
Chourasia AH, Tracy K, Frankenberger C, Boland ML, Sharifi MN, Drake LE, Sachleben JR, Asara JM, Locasale JW, Karczmar GS, Macleod KF. Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis. Embo Reports. 16: 1145-63. PMID 26232272 DOI: 10.15252/Embr.201540759 |
0.71 |
|
| 2015 |
Sharifi MN, Mowers EE, Drake LE, Macleod KF. Measuring autophagy in stressed cells. Methods in Molecular Biology (Clifton, N.J.). 1292: 129-50. PMID 25804753 DOI: 10.1007/978-1-4939-2522-3_10 |
0.672 |
|
| 2014 |
Kuo WL, Sharifi MN, Lingen MW, Ahmed O, Liu J, Nagilla M, Macleod KF, Cohen EE. p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors. Plos One. 9: e90171. PMID 24599075 DOI: 10.1371/Journal.Pone.0090171 |
0.67 |
|
| 2014 |
Chourasia AH, Tracy K, Boland M, Sharifi M, Macleod KF. Abstract 4316: BNIP3 suppresses mammary tumorigenesis and metastasis through negative regulation of Warburg effect and HIF-1α Cancer Research. 74: 4316-4316. DOI: 10.1158/1538-7445.Am2014-4316 |
0.716 |
|
| 2014 |
Sharifi MN, Collier C, Drake L, Chen H, Mui S, Macleod KF. Abstract 321: Autophagy is required for focal adhesion turnover, tumor cell motility and metastasis Cancer Research. 74: 321-321. DOI: 10.1158/1538-7445.Am2014-321 |
0.797 |
|
| 2014 |
Ahmed OG, Kuo W, Wei T, Messer JS, Sharifi M, Nagilla M, Macleod K, Cohen EEW. Abstract 316: Modifying autophagy through combination treatments as a potential therapeutic strategy in head and neck squamous cell carcinoma (HNSCC) Cancer Research. 74: 316-316. DOI: 10.1158/1538-7445.Am2014-316 |
0.709 |
|
| 2013 |
Ahmed O, Kuo W, Nagilla M, Messer JS, Boone DL, Sharifi M, Macleod K, Cohen EE. Synergy with combination of AKT inhibitor (MK-2206) and paclitaxel in head and neck squamous cell carcinoma. Journal of Clinical Oncology. 31: e13532-e13532. DOI: 10.1200/Jco.2013.31.15_Suppl.E13532 |
0.681 |
|
| Show low-probability matches. |